Two‐week interval optical coherence tomography: Imaging evidence on neointimal coverage completion after implantation of the endeavor zotarolimus‐eluting stent
- 17 August 2013
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 82 (7), E871-E878
- https://doi.org/10.1002/ccd.25136
Abstract
Objective To obtain imaging evidence by 2‐week optical coherence tomography (OCT) on the completion of neointimal coverage (NIC; the percentage of stent strut coverage and thickness of the formed neointima) completion after implantation of the Endeavor zotarolimus‐eluting stent (E‐ZES). Background Despite the fact that NIC is a cardinal process in the pathomechanism of late stent thrombosis, little imaging information is available on morphological changes thereof on a short‐time interval basis. Methods 27 Japanese patients with stable angina pectoris and de novo native coronary artery lesions were enrolled, and 27 lesions (30 implantations) were examined. OCT was performed at weeks 2, 4, 6, 8, and 10 after E‐ZES implantation. NIC was examined using cross‐sectional OCT images obtained at the 1.0‐mm intervals. Results In total, 621 cross‐sectional OCT images, which depicted 7,747 stent struts, were analyzed. The mean percentages of stent strut coverage at weeks 2, 4, 6, 8, and 10 after E‐ZES implantation were 12.3, 70.4, 67.9, 86.0, and 99.2%, respectively; a marked increase was found between weeks 2 and 4. The mean thicknesses of the formed neointima were 40.2, 52.1, 48.1, 86.5, and 146.2 μm at respective weeks, with the high‐signal and thick neointima (146 µm) at week 10. An intracoronary thrombus was detected in only one stent at week 4. Conclusions The full circumferential coverage of the vessel wall by the high‐signal neointima was found at as early as week 10 after E‐ZES implantation, imparting a surrogate index for vascular healing by NIC.Keywords
This publication has 18 references indexed in Scilit:
- Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent ThrombosisJACC: Cardiovascular Interventions, 2012
- The Role of Optical Coherence Tomography in Coronary InterventionThe Korean Journal of Internal Medicine, 2012
- Different Patterns of Vascular Response Between Patients With or Without Diabetes Mellitus After Drug-Eluting Stent Implantation: Optical Coherence Tomographic AnalysisJACC: Cardiovascular Interventions, 2010
- Evaluation in 3 Months Duration of Neointimal Coverage After Zotarolimus-Eluting Stent Implantation by Optical Coherence Tomography: The ENDEAVOR OCT TrialJACC: Cardiovascular Interventions, 2009
- Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stentsHeart, 2009
- Safety and Feasibility of an Intravascular Optical Coherence Tomography Image Wire System in the Clinical SettingThe American Journal of Cardiology, 2008
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisCirculation, 2007
- Evaluation by Optical Coherence Tomography of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After ImplantationThe American Journal of Cardiology, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor StentJournal of Interventional Cardiology, 2006